6/2014 |
Grant |
1 |
$1M |
Bill &a; Melinda Gates Foundation
|
10/2007 |
Venture Round |
|
$2M |
|
11/2010 |
Series A |
|
$15M |
|
11/2003 |
Venture Round |
|
$5M |
|
5/2007 |
Venture Round |
|
$2M |
|
4/2008 |
Venture Round |
|
$35M |
|
9/2021 |
Post-IPO Equity |
|
$0 |
Casdin Capital
T. Rowe Price
Illumina
Farallon Capital Management
SoftBank Capital
Perceptive Advisors
Counterpoint Global
ARK Investment Management
Corvex
Janus Henderson Investors
Novartis Pharma
Casdin Capital
T. Rowe Price
Illumina
Farallon Capital Management
SoftBank Capital
Perceptive Advisors
Counterpoint Global
ARK Investment Management
Corvex
Janus Henderson Investors
Novartis Pharma
|
1/2018 |
Venture Round |
|
$0 |
iCarbonX
Madryn Asset Management
Nan Fung Life Sciences
Otsuka Pharmaceutical
ProQuest Investments
Quest Diagnostics
Visium Healthcare Partners
iCarbonX
Madryn Asset Management
Nan Fung Life Sciences
Otsuka Pharmaceutical
ProQuest Investments
Quest Diagnostics
Visium Healthcare Partners
|
12/2020 |
Series A |
|
$0 |
Amgen
Amgen
Boston Millennia Partners
Ziff Capital Partners
Revelation Partners
Redmile Group
Novartis
NEC Solution Innovators
Millennium Management
Logos Capital
Janus Henderson Investors
Intermountain Ventures
Amgen
Amgen
Boston Millennia Partners
Ziff Capital Partners
Revelation Partners
Redmile Group
Novartis
NEC Solution Innovators
Millennium Management
Logos Capital
Janus Henderson Investors
Intermountain Ventures
|
3/2016 |
Debt Financing |
1 |
$60.5M |
Visium Healthcare Partners
Visium Healthcare Partners
|
1/2014 |
Series A |
1 |
- |
dRx Capital
dRx Capital
|
11/2014 |
Venture Round |
|
$0 |
ProQuest Investments
ProQuest Investments
|
8/2010 |
Venture Round |
|
$5M |
|
8/2013 |
Venture Round |
|
$10M |
|
9/2021 |
IPO SPAC |
|
$1.9B |
|
9/2018 |
Equity |
|
$969 |
|
7/2002 |
Venture Round |
|
$8M |
|
4/2020 |
Debt |
|
$2M |
U.S. Small Business Administration.
|
11/2020 |
Series A |
|
$0 |
Casdin Capital
Reimagined Ventures
Blue Water Life Science Fund
Farallon Capital Management
Fiscus Ventures
Foresite Capital
Madryn Asset Management
Monashee Investment Management
Mossrock Capital
Soleus Capital
T. Rowe Price
Casdin Capital
Reimagined Ventures
Blue Water Life Science Fund
Farallon Capital Management
Fiscus Ventures
Foresite Capital
Madryn Asset Management
Monashee Investment Management
Mossrock Capital
Soleus Capital
T. Rowe Price
|
1/2003 |
Venture Round |
|
$19.5M |
|
12/2020 |
Series A |
11 |
$81M |
Casdin Capital
Farallon Capital Management
Foresite Capital
T. Rowe Price Associates, Inc
Madryn Asset Management
Reimagined Ventures
Monashee Investment Management
Soleus Capital
|
11/2020 |
Series A |
11 |
$121M |
Casdin Capital
Farallon Capital Management
Foresite Capital
Casdin Capital
|
9/2021 |
Post-IPO Equity |
11 |
$375M |
Casdin Capital
T. Rowe Price
Illumina
Farallon Capital Management
SoftBank Capital
Perceptive Advisors
Counterpoint Global
ARK Investment Management
Corvex
Janus Henderson Investors
Casdin Capital
T. Rowe Price
Illumina
Farallon Capital Management
SoftBank Capital
Perceptive Advisors
Counterpoint Global
ARK Investment Management
Corvex
Janus Henderson Investors
|
1/2018 |
Venture Round |
7 |
$200M |
iCarbonX
iCarbonX
|
11/2014 |
Venture Round |
1 |
$16.5M |
ProQuest Investments
ProQuest Investments
|
1/2014 |
Series A |
1 |
- |
dRx Capital
dRx Capital
|